GoodRx Holdings, Inc. (GDRX) KPIs and segments
Close on Nov 17, 2026Market cap $1.18BP/E 86.8Yield –
KPIs & segments
Operating metrics and segments that drive GoodRx's business
GoodRx's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription transactions revenue($M) | 106 | 114 | 125 | 127 | 143 | 149 | 145 | 140 | 147 | 145 | 144 | 135 | |
Pharma Direct revenue($M) | 61.6 | 52.2 | 43.4 | 35.0 | 28.6 | 28.1 | 28.1 | 26.5 | 24.5 | 24.4 | 15.9 | ||
Subscription revenue($M) | 28.5 | 24.4 | 21.5 | 20.7 | 20.5 | 21.0 | 20.7 | 21.3 | 22.0 | 22.6 | 23.1 | 23.2 | |
Other revenue($M) | 3.88 | 3.69 | 4.16 | 4.64 | 4.56 | 4.38 | 4.83 | 5.39 | 5.41 | 5.38 | 5.23 | 5.39 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-05.
See a number that looks wrong?